COGNITION THERAPEUTICS INC

Clinical-stage biopharma developing small-molecule drugs for Alzheimer's and dementia.

CGTX | NDAQ

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: United States of America
Address:: 2403 SIDNEY STREET, 15203 PITTSBURGH
Website:: https://cogrx.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Cognition Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, small-molecule therapeutics for age-related neurodegenerative disorders. The company's primary mission is to develop disease-modifying drugs that target the underlying cellular damage mechanisms in the brain. Its lead product candidate, zervimesine (CT1812), is an orally administered molecule designed to protect neurons by restoring key cellular processes impaired by toxic proteins. Cognition Therapeutics' research is concentrated on significant central nervous system (CNS) disorders, with primary areas of focus including Alzheimer's disease and dementia with Lewy bodies (DLB), the two most common forms of degenerative dementia.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all COGNITION THERAPEUTICS INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for COGNITION THERAPEUTICS INC

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for COGNITION THERAPEUTICS INC via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Biovica International B Develops blood tests to monitor the efficacy of solid tumor cancer therapies.	Sweden	BIOVIC
BIOVIE INC. Develops drug therapies for Alzheimer's, Parkinson's, and advanced liver diseases by targeting inflammation.	United States of America	BIVI
BioXcel Therapeutics, Inc. AI-driven biopharma developing treatments for neuroscience and immuno-oncology.	United States of America	BTAI
Black Diamond Therapeutics, Inc. Develops precision oncology drugs targeting mutation families in lung and brain cancers.	United States of America	BDTX
BL Pharmtech Corp. Manufactures and distributes health foods, supplements, and cosmetics with bio-pharmaceutical R&D.	South Korea	065170
BOIRON Global manufacturer of homeopathic medicines for pain relief and flu-like symptoms, sold worldwide.	France	BOI
Bon Natural Life Ltd Bio-manufactures natural plant ingredients for fragrances, supplements, and immunity solutions.	United States of America	BON
Bosnalijek d.d. Sarajevo Global manufacturer of drugs for digestive, metabolic, and cardiovascular health.	Bosnia and Herzegovina	BSNL
Boundless Bio, Inc. Developing ecDNA-directed therapies for intractable oncogene amplified cancers.	United States of America	BOLD
BridgeBio Oncology Therapeutics, Inc. Clinical-stage biopharma creating small molecule drugs for RAS-dependent cancers.	United States of America	BBOT